Exploiting sound for emerging applications of extracellular vesicles DOI
Zhuhao Wu, Hongwei Cai,

Chunhui Tian

et al.

Nano Research, Journal Year: 2023, Volume and Issue: 17(2), P. 462 - 475

Published: July 1, 2023

Language: Английский

Shedding light on ultrasound in action: Optical and optoacoustic monitoring of ultrasound brain interventions DOI Creative Commons
Maria Eleni Karakatsani, Héctor Estrada, Zhenyue Chen

et al.

Advanced Drug Delivery Reviews, Journal Year: 2024, Volume and Issue: 205, P. 115177 - 115177

Published: Jan. 5, 2024

Monitoring brain responses to ultrasonic interventions is becoming an important pillar of a growing number applications employing acoustic waves actuate and cure the brain. Optical interrogation living tissues provides unique means for retrieving functional molecular information related activity disease-specific biomarkers. The hybrid optoacoustic imaging methods have further enabled deep-tissue with optical contrast at high spatial temporal resolution. marriage between light sound thus brings together highly complementary advantages both modalities toward precision interrogation, stimulation, therapy strong impact in fields ultrasound neuromodulation, gene drug delivery, or noninvasive treatments neurological neurodegenerative disorders. In this review, we elaborate on current advances monitoring interventions. We describe main principles mechanisms underlying each method before diving into corresponding biomedical applications. identify areas improvement as well promising approaches clinical translation potential.

Language: Английский

Citations

5

Nanocarrier drug delivery system: promising platform for targeted depression therapy DOI Creative Commons

Xiaoying Feng,

Ping Jia,

Ding-Ding Zhang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: July 25, 2024

Depression is a chronic mental disorder characterized by persistent low mood and loss of interest. Treatments for depression are varied but may not be sufficient cure. Drug-based treatment regimens have drawbacks such as slow onset action, bioavailability, drug side effects. Nanocarrier Drug Delivery Systems (NDDS) has received increasing attention brain delivery since it assists the through blood-brain barrier improves which beneficial treating depression. Due to particle size physicochemical properties nanocarriers, presents promise improve stability solubility antidepressants, thereby enhancing concentration. Moreover, ligand-modified nanocarriers can taken target direct medicines release system reduce The purpose present review provide an up-to-date understanding relevant antidepressants in different routes ingestion, lay foundation patients with

Language: Английский

Citations

5

Open‐Source Throttling of CD8+ T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy DOI
Lei Dong, Yini Zhu,

Haoge Zhang

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(44)

Published: Sept. 12, 2024

Abstract Improving clinical immunotherapy for glioblastoma (GBM) relies on addressing the immunosuppressive tumor microenvironment (TME). Enhancing CD8 + T cell infiltration and preventing its exhaustion holds promise effective GBM immunotherapy. Here, a low‐intensity focused ultrasound (LIFU)‐guided sequential delivery strategy is developed to enhance cells activity in region. The of CXC chemokine ligand 10 (CXCL10) recruit interleukin‐2 (IL‐2) reduce their termed an “open‐source throttling” strategy. Consequently, up 3.39‐fold are observed with LIFU‐guided CXCL10, IL‐2, anti‐programmed death 1 (aPD‐L1), compared free aPD‐L1 group. immune checkpoint inhibitors (ICIs) therapeutic efficacy substantially enhanced by reversed TME due expansion cells, resulting elimination tumor, prolonged survival time, long‐term memory establishment orthotopic mice. Overall, cytokine ICIs offers which may present promising brain‐tumor

Language: Английский

Citations

5

A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease DOI Creative Commons
Amanda D. Currie, Joshua K. Wong, Michael S. Okun

et al.

npj Parkinson s Disease, Journal Year: 2024, Volume and Issue: 10(1)

Published: Oct. 23, 2024

In this review, we summarize preclinical and clinical trials investigating innovative neuromodulatory approaches for Parkinson disease (PD) motor symptom management. We highlight the following technologies: temporal interference, nanoparticles drug delivery, blood-brain barrier opening, gene therapy, optogenetics, upconversion nanoparticles, magnetothermal magnetoelectric ultrasound-responsive designer receptors exclusively activated by drugs. These studies establish basis novel promising treatments PD symptoms.

Language: Английский

Citations

5

Exploiting sound for emerging applications of extracellular vesicles DOI
Zhuhao Wu, Hongwei Cai,

Chunhui Tian

et al.

Nano Research, Journal Year: 2023, Volume and Issue: 17(2), P. 462 - 475

Published: July 1, 2023

Language: Английский

Citations

12